A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

Miní, a wild-born female jaguar, takes an unbelievable journey from the Iberá Wetlands to the Gran Chaco forest to revive a ...

The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.

The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...

New research shows a drug candidate's potential to combat liver disease and atherosclerosis effectively in nonhuman primates.

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

North Texas just wrapped another “nonpartisan” election weekend, but you wouldn’t know it from the partisan flyers, web pages ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...